Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1346 of 5804
-
New acne cream could help transgender men on testosterone without interfering with hormones
Symptom relief OngoingMechanism-based acne treatment for transgender patients receiving testosterone currently does not exist and is an unmet medical need. This study explores clascoterone to treat testosterone induced acne. Many treatments we use to treat acne in females cannot be used in transgender…
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New hope for bile duct cancer: experimental drug targets HER2
Disease control Recruiting nowTo evaluate the efficacy and safety TQB2102 for injection in the treatment of patients with Her2-positive biliary tract cancer.
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New DNA booster shot targets omicron in small trial
⭐️ VACCINE ⭐️ CompletedCurrently, several vaccines are available to combat the COVID-19 pandemic. The persistence of SARS-CoV-2 globally requires the development of additional vaccines to aid in preventing further SARS-CoV-2 infections. Covigenix VAX-002 is a vaccine based off its predecessors VAX-001 …
Phase: PHASE1, PHASE2 • Sponsor: Entos Pharmaceuticals Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:04 UTC
-
New pill hopes to slow Parkinson's in early stages
Disease control Completed1. Study Objective \- To assess the efficacy and safety of vutiglabridin in early Parkindson's disease patients 2. Background Glaceum Inc. has evaluated the safety, tolerability, and pharmacokinetic/pharmacodynamic properties of vutiglabridin in healthy subjects through its P…
Phase: PHASE2 • Sponsor: Glaceum • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New blood clot pill could replace daily shots for joint replacement patients
Prevention CompletedThis clinical study aims to evaluate the efficacy and safety of the anticoagulant Dimolegin® compared to low molecular weight heparin (Clexane®) for the prevention of venous thromboembolic events (VTE) in patients undergoing major joint (hip or knee) replacement surgery. The stud…
Phase: PHASE3 • Sponsor: Avexima Diol LLC • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Alzheimer's vaccine trial aims to stop brain protein buildup
Disease control OngoingThe purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, using brain scan (tau PET) to determine results from specific areas of the brain.
Phase: PHASE2 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for hard-to-treat leukemia: old drug shows promise in combo therapy
Disease control Recruiting nowThis is an open label, phase 1 study for AML subjects with relapsed or refractory disease or subjects in morphologic remission with MRD+ after first line therapy with venetoclax+HMA. A preliminary dose-finding cohort will be followed by 3 expansion cohorts.
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Brain zaps show promise for autism symptoms in small trial
Symptom relief CompletedAutism spectrum disorder (ASD) is a complex neurodevelopmental disorder with core symptoms that include impairments in social communication and restricted and repetitive behaviors, interests, and activities. Social cognition is a broad term used to understand, perceive, and inter…
Phase: NA • Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New biologic shows promise for Tough-to-Treat ulcerative colitis
Disease control CompletedThe goal of this study is to confirm that Mirikizumab therapy may provide clinical, endoscopic, and histopathologic improvements in patients with moderate to severe UC refractory to maintenance therapy when high neutrophilic infiltration in epithelium of the colonic mucosa (Geboe…
Phase: PHASE4 • Sponsor: Showa Inan General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New antibody A-319 takes aim at Hard-to-Treat lupus
Disease control Recruiting nowThe purpose of the study is to explore the safety and efficacy of recombinant CD19xCD3 double antibody (A-319) in active/refractory systemic lupus erythematosus (SLE).
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 26, 2026 17:45 UTC
-
Vitamin c boost: could it make chemo safer for myeloma patients?
Disease control Recruiting nowThe purpose of this research is to evaluate whether HDAA in combination with a single dose of 100 mg/m2 IV melphalan followed by autologous stem cell transplantation (ASCT) is safe and effective for subjects with relapsed refractory multiple myeloma. The proposed melphalan dose i…
Phase: PHASE1 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Power training could help kids with cerebral palsy reach their goals
Symptom relief Recruiting nowRationale: Children with cerebral palsy (CP) experience limitations in walking ability due to functional motor impairments caused by neurodevelopmental damage during fetal or early child development. Due to these motor impairments, children with CP struggle to keep up with typica…
Phase: NA • Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New asthma drug aims to clear mucus and protect airways
Disease control Recruiting nowAsthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of …
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
RNA editing drug hopes to fix genetic flaw in rare lung and liver disease
Disease control OngoingThe purpose of this open-label study is to assess the safety, tolerability, pharmacodynamics, and pharmacokinetics of WVE-006 in participants with alpha-1 antitrypsin deficiency (AATD) following Period 1 single ascending dose (SAD) and Period 2 multiple ascending doses (MAD), res…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New asthma injection shows promise in early trial
Disease control Recruiting nowThe purpose of this study is to evaluation the long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a 3-Month pill course spare older breast cancer patients from radiation?
Disease control Recruiting nowThis is a Phase III, multisite exploratory study for women ≥ 65 years of age with early stage estrogen receptor positive (ER+) breast cancer. These individuals will be treated randomly assigned to one of two groups: Intervention, treated with 3 months of pre-operative endocrine …
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New device for kids with kidney failure under safety watch
Disease control Recruiting nowQUELIMMUNE is FDA-approved under an HDE for the treatment of pediatric patients (weight ≥10kg and age ≤22 years) with AKI due to sepsis or a septic condition on antibiotic therapy and requiring RRT. The purpose of this surveillance registry is to prospectively collect safety dat…
Sponsor: SeaStar Medical • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New Gear-Shifting wheelchair aims to save shoulders
Symptom relief Recruiting nowOver one million Americans rely on their upper extremities for manual wheelchair propulsion. Shoulder overuse injuries are prevalent among manual wheelchair users and these injuries often result in shoulder pain. Severe shoulder pain can lead some wheelchair users to transition f…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Firefighter trainees get mental health training to prevent PTSD and depression
Prevention ENROLLING_BY_INVITATIONThe goal of this clinical trial is to determine if a peer-delivered emotion regulation training (Brief-Unified Protocol) workshop is effective for preventing posttraumatic stress and other psychological health symptoms in firefighter trainees. The main questions it aims to answer…
Phase: NA • Sponsor: Baylor Research Institute • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
AI-Powered stethoscope could save newborns from missed heart defects
Diagnosis Recruiting nowNeonatal screening procedures for potentially life-threatening congenital cardiovascular diseases (i.e., duct-dependent systemic or pulmonary circulation), currently implemented at the national level, rely primarily on cardiovascular physical examination performed by a neonatolog…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC